Law Firm BFA Investigates Tempus AI's $16.25 per Share Deal for Personalis
Securities law firm Bleichmar Fonti & Auld LLP (BFA) says it is investigating the merger in which Tempus AI, Inc. is taking Personalis, Inc. (NASDAQ: PSNL) private at $16.25 per share. The firm is looking at possible breaches of fiduciary duty and at whether the price is fair to public stockholders.
- Bleichmar Fonti & Auld LLP is investigating Tempus AI's take-private merger of Personalis (NASDAQ: PSNL) at $16.25 per share.
- The deal was announced July 20, 2026 and allows a mix of cash and stock consideration, according to BFA.
- As of March 2026, Tempus AI owned 12.5% of Personalis' outstanding common stock, and the companies have had a commercial relationship since November 2023.
- BFA is examining Delaware law compliance, possible fiduciary duty breaches and whether the price is fair.
- The firm says representation is on a contingency fee basis at no cost to shareholders.
What the investigation covers
In a release distributed through PR Newswire on Oct. 27, 2026, BFA said it is examining the going private merger of Personalis, which is incorporated in Delaware. The firm describes the focus of its investigation as breaches of fiduciary duty in connection with the deal, in which Personalis' commercial associate, Tempus AI, is taking the company private.
According to BFA, the central questions are whether the merger terms comply with Delaware law, whether Tempus' earlier relationship with Personalis caused related breaches of fiduciary duty, and whether the per share price is a fair price for the public stockholders' shares.
The deal and the Tempus relationship
BFA says Personalis announced the merger on July 20, 2026. In that announcement, Personalis disclosed it was being taken private by Tempus AI in a structure that allows for a mix of cash and stock consideration, anchored to a price of $16.25 per share of Personalis stock.
The law firm points to the existing ties between the two companies as the reason for scrutiny. As of March 2026, Tempus AI owned 12.5% of Personalis' outstanding common stock, according to BFA. The firm adds that since November 2023, Tempus has been in an ongoing commercial relationship with Personalis for commercialization and laboratory services.
The release does not state any finding of wrongdoing. It describes an investigation into whether the terms and price are appropriate.
What BFA is asking of shareholders
BFA encourages current Personalis stockholders to contact the firm and submit their information through a page on its website. The firm says current holders may have legal options.
According to the release, all representation is on a contingency fee basis, meaning there is no cost to shareholders. BFA states that shareholders are not responsible for any court costs or expenses of litigation, and that the firm will seek court approval for any potential fees and expenses.
BFA describes itself as a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It cites recoveries of over $900 million in value from Tesla, Inc.'s Board of Directors and $420 million from Teva Pharmaceutical Ind. Ltd. The release carries an attorney advertising notice and says past results do not guarantee future outcomes.
What it means for Personalis holders
The announcement is a law firm's investigation notice, not a lawsuit or a court ruling. For Personalis stockholders, it signals that questions are being raised about the fairness of the $16.25 per share price and the role of Tempus AI's prior stake and commercial relationship. Whether the investigation leads to any legal action is not addressed in the release.
